The Era of Biomedicine: Science, Medicine, and Public Health in Britain and France after the Second World War

Abstract

The relationship between medicine and the study of life is as old as medicine itself. Nevertheless, historians have highlighted the great transformation that took place in the nineteenth century when first physiology and then bacteriology became important resources for the classification, diagnosis, and treatment of human diseases.1 In that period, significant links developed between the sites specializing in biological experimentation (i.e. laboratories) on the one hand, and the places of healing (i.e. hospitals, dispensaries) and public health offices on the other. Together, they helped to fashion modern, professional medicine.2 However, many historical studies have also argued that this mobilization of biological knowledge exerted a limited impact on medical practice in general, and clinical practice in particular.

Innovation strategy management survey of the Chilean biomedical industry. Assessment of windows of opportunities to reduce technological gaps

“…The foundation of the biomedical industry as we know it today dates back to the 1940s, as a consequence of the increase of research related to life, the search for new molecules, health technology assessment, and the efforts of nations to improve people's health. 43 This industry is composed of many subjects ranging from medicine, mechanics, electronics, material engineering, pharmacology, medical devices, biomaterials, nanomedicine, biophysics, biochemistry, physiology, physiopathology, genetics, and immunology to cell biology. The objective of these fields is the study of biological factors to prevent, diagnose, treat, reduce, or determine the severity or prevalence of a specific disease or medical condition through R&D and innovation.…”

What can an evolutionary perspective on women’s health provide to the current public health paradigm? A case study on redefining thyroid cancer as a reproductive cancer

“…Politicisation of healthcare as caused by the welfare state creates structural barriers to interdisciplinary research. Power over of health policy has been ceded by politicians to the medical profession given their importance in the running of the NHS (Quirke, Gaudillière 2008). This places professionals with a biomedical background in positions of authority regarding public health funding (Quirke, Gaudillière 2008).…”

Translational biomedicine in action: Constructing biomarkers across laboratory and benchside

“…However only a few contributions have explored the recurring interactions between the laboratory, bench and clinic (Löwy, 1996;Quirke and Gaudillière, 2008). Traditionally, scientific research and clinical practices have been understood to be profoundly different, and sometimes conflicting, activities because of their different epistemological, cultural and ethical orientations (Morgan et al, 2011).…”